251 related articles for article (PubMed ID: 21411011)
1. The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria.
Mimche PN; Taramelli D; Vivas L
Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S10. PubMed ID: 21411011
[TBL] [Abstract][Full Text] [Related]
2. Conventional and experimental treatment of cerebral malaria.
Golenser J; McQuillan J; Hee L; Mitchell AJ; Hunt NH
Int J Parasitol; 2006 May; 36(5):583-93. PubMed ID: 16603167
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory therapy associated to anti-parasite drugs as a way to prevent severe forms of malaria.
Muniz-Junqueira MI
Curr Clin Pharmacol; 2007 Jan; 2(1):59-73. PubMed ID: 18690855
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cerebral malaria by curcumin as an adjunctive therapy.
Jain K; Sood S; Gowthamarajan K
Braz J Infect Dis; 2013; 17(5):579-91. PubMed ID: 23906771
[TBL] [Abstract][Full Text] [Related]
5. A single rapamycin dose protects against late-stage experimental cerebral malaria via modulation of host immunity, endothelial activation and parasite sequestration.
Mejia P; Treviño-Villarreal JH; Reynolds JS; De Niz M; Thompson A; Marti M; Mitchell JR
Malar J; 2017 Nov; 16(1):455. PubMed ID: 29121917
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory effect of Sambucol on leishmanial and malarial infections.
Waknine-Grinberg JH; El-On J; Barak V; Barenholz Y; Golenser J
Planta Med; 2009 May; 75(6):581-6. PubMed ID: 19214946
[TBL] [Abstract][Full Text] [Related]
7. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cerebral malaria by fasudil and other immune-modifying compounds.
Waknine-Grinberg JH; McQuillan JA; Hunt N; Ginsburg H; Golenser J
Exp Parasitol; 2010 Jun; 125(2):141-6. PubMed ID: 20093114
[TBL] [Abstract][Full Text] [Related]
9. Brain Endothelium: The "Innate Immunity Response Hypothesis" in Cerebral Malaria Pathogenesis.
Pais TF; Penha-Gonçalves C
Front Immunol; 2018; 9():3100. PubMed ID: 30761156
[TBL] [Abstract][Full Text] [Related]
10. Emerging avenues for the management of cerebral malaria.
Das N; Prabhu P
J Pharm Pharmacol; 2022 Jun; 74(6):800-811. PubMed ID: 35429389
[TBL] [Abstract][Full Text] [Related]
11. Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria.
Dende C; Meena J; Nagarajan P; Panda AK; Rangarajan PN; Padmanaban G
Sci Rep; 2015 Jul; 5():12671. PubMed ID: 26227888
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive therapy for severe malaria: a review and critical appraisal.
Varo R; Crowley VM; Sitoe A; Madrid L; Serghides L; Kain KC; Bassat Q
Malar J; 2018 Jan; 17(1):47. PubMed ID: 29361945
[TBL] [Abstract][Full Text] [Related]
13. Activated Neutrophils Are Associated with Pediatric Cerebral Malaria Vasculopathy in Malawian Children.
Feintuch CM; Saidi A; Seydel K; Chen G; Goldman-Yassen A; Mita-Mendoza NK; Kim RS; Frenette PS; Taylor T; Daily JP
mBio; 2016 Feb; 7(1):e01300-15. PubMed ID: 26884431
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology?
Medana IM; Chaudhri G; Chan-Ling T; Hunt NH
Immunol Cell Biol; 2001 Apr; 79(2):101-20. PubMed ID: 11264703
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria.
Higgins SJ; Kain KC; Liles WC
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):803-19. PubMed ID: 21905788
[TBL] [Abstract][Full Text] [Related]
16. Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria.
Dende C; Meena J; Nagarajan P; Nagaraj VA; Panda AK; Padmanaban G
Sci Rep; 2017 Aug; 7(1):10062. PubMed ID: 28855623
[TBL] [Abstract][Full Text] [Related]
17. IL-4 Treatment Mitigates Experimental Cerebral Malaria by Reducing Parasitemia, Dampening Inflammation, and Lessening the Cytotoxicity of T Cells.
Wu X; Thylur RP; Dayanand KK; Punnath K; Norbury CC; Gowda DC
J Immunol; 2021 Jan; 206(1):118-131. PubMed ID: 33239419
[TBL] [Abstract][Full Text] [Related]
18. [Physiopathology of cerebral malaria].
Gachot B; Vachon F
Presse Med; 1995 Apr; 24(13):642-6. PubMed ID: 7761365
[TBL] [Abstract][Full Text] [Related]
19. Beta interferon suppresses the development of experimental cerebral malaria.
Morrell CN; Srivastava K; Swaim A; Lee MT; Chen J; Nagineni C; Hooks JJ; Detrick B
Infect Immun; 2011 Apr; 79(4):1750-8. PubMed ID: 21245265
[TBL] [Abstract][Full Text] [Related]
20. Synthetic oleanane triterpenoids enhance blood brain barrier integrity and improve survival in experimental cerebral malaria.
Crowley VM; Ayi K; Lu Z; Liby KT; Sporn M; Kain KC
Malar J; 2017 Nov; 16(1):463. PubMed ID: 29137631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
